Published in J Neurosurg on October 01, 2010
Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication. Vasc Med (2011) 0.78
Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke. Brain Res (2014) 0.76
Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice. J Neurosci Res (2014) 0.75
Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study. Stroke (2003) 3.15
Increased inspired oxygen concentration as a factor in improved brain tissue oxygenation and tissue lactate levels after severe human head injury. J Neurosurg (1999) 3.12
A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke (2005) 2.58
Effect of hyperoxia on regional oxygenation and metabolism after severe traumatic brain injury: preliminary findings. Crit Care Med (2008) 2.42
Effect of hyperoxia on cerebral metabolic rate for oxygen measured using positron emission tomography in patients with acute severe head injury. J Neurosurg (2007) 2.22
Increase in cerebral aerobic metabolism by normobaric hyperoxia after traumatic brain injury. J Neurosurg (2008) 1.94
Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain (2007) 1.92
Mechanisms of hyperbaric oxygen and neuroprotection in stroke. Pathophysiology (2005) 1.89
Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab (2005) 1.84
Normobaric hyperoxia--induced improvement in cerebral metabolism and reduction in intracranial pressure in patients with severe head injury: a prospective historical cohort-matched study. J Neurosurg (2004) 1.80
Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology (2002) 1.67
Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery. Crit Care Med (2000) 1.62
Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab (2002) 1.59
Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (2007) 1.57
Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. J Neurosurg (2001) 1.57
Hyperbaric oxygen in the treatment of acute ischemic stroke: an unsettled issue. J Neurol Sci (1997) 1.55
Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol (2005) 1.42
Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia. Stroke (2007) 1.30
Eubaric hyperoxemia and experimental cerebral infarction. Ann Neurol (2002) 1.26
Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke. J Neurochem (2008) 1.24
The effect of the red cell membrane and a diffusion boundary layer on the rate of oxygen uptake by human erythrocytes. J Physiol (1981) 1.22
A review of oxygen therapy in ischemic stroke. Neurol Res (2007) 1.20
Therapeutic window for use of hyperbaric oxygenation in focal transient ischemia in rats. Stroke (2004) 1.19
Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke (2005) 1.13
Hyperbaric oxygen in the treatment of patients with cerebral stroke, brain trauma, and neurologic disease. Adv Ther (2006) 1.13
Is there a role for hyperoxia in the management of severe traumatic brain injury? J Neurosurg (2007) 1.12
Effect of diffusion boundary layers on the initial uptake of O2 by red cells. Theory versus experiment. Microvasc Res (1983) 1.12
Dual effect of HBO on cerebral infarction in MCAO rats. Am J Physiol Regul Integr Comp Physiol (2001) 1.08
Effects of cerebral perfusion pressure and increased fraction of inspired oxygen on brain tissue oxygen, lactate and glucose in patients with severe head injury. Acta Neurochir (Wien) (2003) 1.05
Hyperoxia: good or bad for the injured brain? Curr Opin Crit Care (2008) 1.04
Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. Stroke (1995) 1.04
Neuroprotection by hyperbaric oxygenation after experimental focal cerebral ischemia monitored by MRI. Stroke (2004) 1.01
Oxygen therapy in permanent brain ischemia: potential and limitations. Brain Res (2006) 1.01
Hyperbaric oxygen therapy for stroke: a systematic review of the evidence. Clin Rehabil (2005) 0.99
A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke (1991) 0.98
Neuroprotection by oxygen in acute transient focal cerebral ischemia is dose dependent and shows superiority of hyperbaric oxygenation. Cerebrovasc Dis (2008) 0.98
Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev (2005) 0.97
Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats. Brain Res (2000) 0.97
Cerebral oxygenation in patients after severe head injury: monitoring and effects of arterial hyperoxia on cerebral blood flow, metabolism and intracranial pressure. J Neurosurg Anesthesiol (1999) 0.97
Delayed hyperbaric oxygenation is more effective than early prolonged normobaric hyperoxia in experimental focal cerebral ischemia. Neurosci Lett (2007) 0.96
Hyperbaric oxygenation as an adjunct therapy in strokes due to thrombosis. A review of 122 patients. Stroke (1980) 0.95
Hyperbaric oxygen treatment attenuated the decrease in regional glucose metabolism of rats subjected to focal cerebral ischemia: a high resolution positron emission tomography study. Neuroscience (2007) 0.95
Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovasc Dis (2005) 0.92
Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. Brain Res (2002) 0.92
Results of hyperbaric oxygen therapy during temporary middle cerebral artery occlusion in unanesthetized cats. Neurosurgery (1987) 0.91
Delayed and multiple hyperbaric oxygen treatments expand therapeutic window in rat focal cerebral ischemic model. Neurocrit Care (2005) 0.90
Kinetics of O2 uptake and release by human erythrocytes studied by a stopped-flow technique. J Appl Physiol (1985) (1985) 0.90
Neuroprotective effect of hyperbaric oxygen therapy monitored by MR-imaging after embolic stroke in rats. Exp Neurol (2006) 0.89
The carotenoid crocetin enhances pulmonary oxygenation. J Appl Physiol (1985) (1988) 0.87
Trans-sodium crocetinate and hemorrhagic shock. Shock (2007) 0.86
Therapeutic effects of hyperbaric oxygen in a rat model of endothelin-1-induced focal cerebral ischemia. Brain Res (2007) 0.85
trans-Sodium crocetinate and diffusion enhancement. J Phys Chem B (2006) 0.84
Differential hydroxylation of salicylate in core and penumbra regions during focal reversible cerebral ischemia. Stroke (1997) 0.83
Oxygen therapy in ischemic stroke. Stroke (2003) 0.82
The effect of crocetin on hemorrhagic shock in rats. Circ Shock (1993) 0.81
Hyperbaric oxygen therapy of acute ischemic stroke. Stroke (2007) 0.81
Therapeutic effects of hyperbaric oxygenation on acute focal cerebral ischemia in rats. Surg Neurol (1990) 0.80
Hyperoxia and traumatic brain injury. J Neurosurg (2009) 0.80
Trans-sodium crocetinate increases oxygen delivery to brain parenchyma in rats on oxygen supplementation. Neurosci Lett (2003) 0.80
Effects of intraischemic hypothermia on cerebral damage in a model of reversible focal ischemia. Neurosurgery (1993) 0.79
Hyperbaric oxygen and cerebral infarction in the gerbil. Surg Neurol (1987) 0.79
Carotenoid compound crocetin improves cerebral oxygenation in hemorrhaged rats. J Cereb Blood Flow Metab (1986) 0.79
A novel fluid resuscitation therapy for hemorrhagic shock. Shock (1998) 0.78
A review of the scientific evidence on the treatment of traumatic brain injuries and strokes with hyperbaric oxygen. Brain Inj (2003) 0.78
A reproducible model of reversible, focal, neocortical ischemia in Sprague-Dawley rat. Acta Neurochir (Wien) (1993) 0.78
Hyperoxia. J Neurosurg (2008) 0.76
Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol (2010) 5.23
Spreading depolarisations and outcome after traumatic brain injury: a prospective observational study. Lancet Neurol (2011) 2.40
Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour. Nature (2016) 2.21
Neurostimulation for traumatic brain injury. J Neurosurg (2014) 2.10
Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery (2003) 2.07
No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys. J Virol (2007) 1.89
Occipital condyle fractures: clinical decision rule and surgical management. J Neurosurg Spine (2009) 1.85
Long-term outcomes and prognostic factors in pediatric patients with severe traumatic brain injury and elevated intracranial pressure. J Neurosurg Pediatr (2008) 1.69
Complications and radiographic correction in adult scoliosis following combined transpsoas extreme lateral interbody fusion and posterior pedicle screw instrumentation. Neurosurg Focus (2010) 1.65
Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nat Neurosci (2012) 1.58
Early induction of hypothermia for evacuated intracranial hematomas: a post hoc analysis of two clinical trials. J Neurosurg (2012) 1.57
Magnetic resonance imaging improves 3-month outcome prediction in mild traumatic brain injury. Ann Neurol (2012) 1.55
Single-center experience with pediatric Cushing's disease. J Neurosurg (2005) 1.54
Complications in adult spinal deformity surgery: an analysis of minimally invasive, hybrid, and open surgical techniques. Neurosurg Focus (2014) 1.51
Symptomatology and functional outcome in mild traumatic brain injury: results from the prospective TRACK-TBI study. J Neurotrauma (2013) 1.51
Comparative effectiveness of using computed tomography alone to exclude cervical spine injuries in obtunded or intubated patients: meta-analysis of 14,327 patients with blunt trauma. J Neurosurg (2011) 1.47
High-definition fiber tracking for assessment of neurological deficit in a case of traumatic brain injury: finding, visualizing, and interpreting small sites of damage. J Neurosurg (2012) 1.45
Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping. Ann Thorac Surg (2006) 1.44
Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma (2013) 1.40
Transforming research and clinical knowledge in traumatic brain injury pilot: multicenter implementation of the common data elements for traumatic brain injury. J Neurotrauma (2013) 1.28
Translational systems approaches to the biology of inflammation and healing. Immunopharmacol Immunotoxicol (2010) 1.18
Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus (2008) 1.16
Prospective independent validation of IMPACT modeling as a prognostic tool in severe traumatic brain injury. J Neurotrauma (2011) 1.13
Translational systems biology of inflammation: potential applications to personalized medicine. Per Med (2010) 1.11
Outcome following decompressive craniectomy in children with severe traumatic brain injury: a 10-year single-center experience with long-term follow up. J Neurosurg (2007) 1.10
Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury. Exp Neurol (2004) 1.09
Thoracolumbar spinal deformity: Part I. A historical passage to 1990: historical vignette. J Neurosurg Spine (2009) 1.09
Thoracolumbar spinal deformity: Part II. Developments from 1990 to today: historical vignette. J Neurosurg Spine (2009) 1.08
Spreading depolarizations have prolonged direct current shifts and are associated with poor outcome in brain trauma. Brain (2011) 1.08
A murine model of subarachnoid hemorrhage-induced cerebral vasospasm. J Neurosci Methods (2003) 1.08
Diffusion tensor imaging for outcome prediction in mild traumatic brain injury: a TRACK-TBI study. J Neurotrauma (2014) 1.06
Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid Beta peptide in traumatic axonal injury. J Neurotrauma (2002) 1.05
Intraoperative computed tomography image-guided navigation for posterior thoracolumbar spinal instrumentation in spinal deformity surgery. Neurosurg Focus (2010) 1.05
Effect of analgesics and sedatives on the occurrence of spreading depolarizations accompanying acute brain injury. Brain (2012) 1.04
Fractures of the clivus: a contemporary series in the computed tomography era. Neurosurgery (2009) 1.03
Perioperative surgical complications of transforaminal lumbar interbody fusion: a single-center experience. J Neurosurg Spine (2011) 1.00
The antimicrobial and osteoinductive properties of silver nanoparticle/poly (DL-lactic-co-glycolic acid)-coated stainless steel. Biomaterials (2012) 0.99
Cerebral pressure autoregulation in traumatic brain injury. Neurosurg Focus (2008) 0.99
GABAergic synaptic inhibition is reduced before seizure onset in a genetic model of cortical malformation. J Neurosci (2006) 0.98
Thromboprophylaxis in traumatic and elective spinal surgery: analysis of questionnaire response and current practice of spine trauma surgeons. Spine (Phila Pa 1976) (2010) 0.96
MRI is unnecessary to clear the cervical spine in obtunded/comatose trauma patients: the four-year experience of a level I trauma center. J Trauma (2008) 0.95
Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome. J Neurosurg (2005) 0.94
Predictors of complications after spinal stabilization of thoracolumbar spine injuries. J Trauma (2010) 0.94
Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients. J Trauma Acute Care Surg (2015) 0.93
Induced normothermia attenuates intracranial hypertension and reduces fever burden after severe traumatic brain injury. Neurocrit Care (2009) 0.93
Neuroglobin genetic polymorphisms and their relationship to functional outcomes after traumatic brain injury. J Neurotrauma (2010) 0.93
The impact of facet dislocation on clinical outcomes after cervical spinal cord injury: results of a multicenter North American prospective cohort study. Spine (Phila Pa 1976) (2013) 0.93
Surgical management of post-traumatic syringomyelia. Spine (Phila Pa 1976) (2010) 0.92
The brain in vivo expresses the 2',3'-cAMP-adenosine pathway. J Neurochem (2012) 0.92
BCL2 genotypes: functional and neurobehavioral outcomes after severe traumatic brain injury. J Neurotrauma (2010) 0.91
The impact of previous traumatic brain injury on health and functioning: a TRACK-TBI study. J Neurotrauma (2013) 0.91
Outcome prediction after mild and complicated mild traumatic brain injury: external validation of existing models and identification of new predictors using the TRACK-TBI pilot study. J Neurotrauma (2014) 0.90
Reconstruction of the sellar dura in transsphenoidal surgery using an expanded polytetrafluoroethylene dural substitute. Surg Neurol (2008) 0.90
Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm. Surg Neurol (2005) 0.89
The evolution of ischemic spinal cord injury in function, cytoarchitecture, and inflammation and the effects of adenosine A2A receptor activation. J Thorac Cardiovasc Surg (2004) 0.89
NELL-1 promotes cell adhesion and differentiation via Integrinβ1. J Cell Biochem (2012) 0.88
Illuminating protein interactions in tissue using confocal and two-photon excitation fluorescent resonance energy transfer microscopy. J Biomed Opt (2003) 0.87
Trans-sodium crocetinate and hemorrhagic shock. Shock (2007) 0.86
Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma. J Surg Res (2004) 0.86
Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injury. Neurogenetics (2015) 0.86
Characteristics of hypothermic preconditioning influencing the induction of delayed ischemic tolerance. J Neurosurg (2002) 0.86
Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study. Neurosurgery (2003) 0.85
Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging. J Neurotrauma (2015) 0.85
Hypothermic preconditioning induces rapid tolerance to focal ischemic injury in the rat. Exp Neurol (2003) 0.84
trans-Sodium crocetinate and diffusion enhancement. J Phys Chem B (2006) 0.84
Effect of short periods of normobaric hyperoxia on local brain tissue oxygenation and cerebrospinal fluid oxidative stress markers in severe traumatic brain injury. J Neurotrauma (2009) 0.84
Radiographic and clinical outcomes following combined lateral lumbar interbody fusion and posterior segmental stabilization in patients with adult degenerative scoliosis. Neurosurg Focus (2014) 0.83
The minimally invasive spinal deformity surgery algorithm: a reproducible rational framework for decision making in minimally invasive spinal deformity surgery. Neurosurg Focus (2014) 0.83
Less invasive surgery for treating adult spinal deformities: ceiling effects for deformity correction with 3 different techniques. Neurosurg Focus (2014) 0.82
Fractures of the clivus and traumatic diastasis of the central skull base in the pediatric population. J Neurosurg Pediatr (2011) 0.82
Trans sodium crocetinate for hemorrhagic shock: effect of time delay in initiating therapy. Shock (2002) 0.82
Influence of PARP-1 polymorphisms in patients after traumatic brain injury. J Neurotrauma (2010) 0.82
Detection of white matter injury in concussion using high-definition fiber tractography. Prog Neurol Surg (2014) 0.81
Intermittent versus continuous cerebrospinal fluid drainage management in adult severe traumatic brain injury: assessment of intracranial pressure burden. Neurocrit Care (2014) 0.81
Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism. J Vasc Surg (2006) 0.80
Technical nuances of the minimally invasive extreme lateral approach to treat thoracolumbar burst fractures. Eur Spine J (2015) 0.80
TSC for hemorrhagic shock: effects on cytokines and blood pressure. Shock (2004) 0.80
Impaired bone mineral density as a predictor of graft subsidence following minimally invasive transpsoas lateral lumbar interbody fusion. Eur Spine J (2015) 0.80
Comparison of two minimally invasive surgery strategies to treat adult spinal deformity. J Neurosurg Spine (2015) 0.80
Early adenosine receptor activation ameliorates spinal cord reperfusion injury. J Cardiovasc Med (Hagerstown) (2008) 0.79
Mitochondrial polymorphisms impact outcomes after severe traumatic brain injury. J Neurotrauma (2013) 0.79
Lifetime attributable risk of cancer from CT among patients surviving severe traumatic brain injury. AJR Am J Roentgenol (2013) 0.79
Comparison of radiographic results after minimally invasive, hybrid, and open surgery for adult spinal deformity: a multicenter study of 184 patients. Neurosurg Focus (2014) 0.78
Arachnoid diverticula associated with anterior cranial base tumors: technical case report. Neurosurgery (2007) 0.78
Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication. Vasc Med (2011) 0.78
Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction. J Cardiothorac Vasc Anesth (2002) 0.78
Fed-batch microbioreactor platform for scale down and analysis of a plasmid DNA production process. Biotechnol Bioeng (2012) 0.78
Premorbid oral antithrombotic therapy and risk for reaccumulation, reoperation, and mortality in acute subdural hematomas. J Neurosurg (2010) 0.78
Breaking Through the "Glass Ceiling" of Minimally Invasive Spine Surgery. Spine (Phila Pa 1976) (2016) 0.78
319 Predictive Value of Intraoperative Neurophysiological Monitoring During Spine Surgery: A Prospective Analysis of 4489 Consecutive Patients. Neurosurgery (2016) 0.78
Attenuation of hemolysate-induced cerebrovascular endothelial cell injury and of production of endothelin-1 and big endothelin-1 by an endothelin-converting enzyme inhibitor. Surg Neurol (2002) 0.77
Minimal-access technique for distal catheter insertion during ventricular peritoneal shunt procedures: a review of 100 cases. J Neurosurg (2009) 0.77
Does Minimally Invasive Percutaneous Posterior Instrumentation Reduce Risk of Proximal Junctional Kyphosis in Adult Spinal Deformity Surgery? A Propensity-Matched Cohort Analysis. Neurosurgery (2016) 0.77
Future of rewarming in therapeutic hypothermia for traumatic brain injury: a personalized plan. Ther Hypothermia Temp Manag (2010) 0.77
Flumazenil administration attenuates cognitive impairment in immature rats after controlled cortical impact. J Neurotrauma (2010) 0.77
Corrigendum: Structural and functional features of central nervous system lymphatic vessels. Nature (2016) 0.77
Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury. Neurocrit Care (2013) 0.77
Magnetoencephalographic virtual recording: a novel diagnostic tool for concussion. Neurosurg Focus (2012) 0.77
Metabolic reflow as a therapy for ischemic brain injury. Acta Neurochir Suppl (2011) 0.77
Vertebral body fracture following stand-alone lateral lumbar interbody fusion (LLIF): report of two events out of 712 levels. Eur Spine J (2015) 0.76